4,155
Views
18
CrossRef citations to date
0
Altmetric
Review

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss & David M G Halpin. (2021) Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 499-517.
Read now
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Mario Cazzola & Paola Rogliani. (2020) Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review. Expert Review of Respiratory Medicine 14:6, pages 621-635.
Read now
Kirsten Koehorst-ter Huurne, Catharina GM Groothuis-Oudshoorn, Paul DLPM vanderValk, Kris LL Movig, Job van der Palen & Marjolein Brusse-Keizer. (2018) Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1683-1690.
Read now
Peter M. A. Calverley, Helgo Magnussen, Marc Miravitlles & Jadwiga A. Wedzicha. (2017) Triple Therapy in COPD: What We Know and What We Don't. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:6, pages 648-662.
Read now
Valentina Perrone, Diego Sangiorgi, Stefano Buda & Luca Degli Esposti. (2016) Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2749-2755.
Read now

Articles from other publishers (13)

Kevin I. Duan, Laura J. Spece, Edwin S. Wong, Laura C. Feemster, Lucas M. Donovan, Matthew F. Griffith, Thomas L. Keller, Alexander D. Bryant & David H. Au. (2021) Low-Value Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease and the Association with Healthcare Utilization and Costs. Annals of the American Thoracic Society 18:6, pages 989-996.
Crossref
Jooyeon Lee & Se-Ran Yang. (2021) Lung organoids: target cells for understanding respiratory diseases. Organoid 1, pages e4.
Crossref
María Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019. Archivos de Bronconeumología 56:2, pages 106-113.
Crossref
Maria Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019. Archivos de Bronconeumología (English Edition) 56:2, pages 106-113.
Crossref
Krysttel Stryczek, Colby Lea, Chris Gillespie, George Sayre, Scott Wanner, Seppo T. Rinne, Renda Soylemez Wiener, Laura Feemster, Edmunds Udris, David H. Au & Christian D. Helfrich. (2019) De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers’ Perspectives. Journal of General Internal Medicine 35:1, pages 51-56.
Crossref
Shinichiro Okauchi, Kensuke Kinoshita, Shinya Sato, Hajime Osawa, Hideyasu Yamada, Kunihiko Miyazaki, Hiroaki Satoh, Nobuyuki Hizawa & Hiroyuki Kobayashi. (2019) Rinsing of oropharynx and storage place of respiratory medicine inhaler: A cross‐sectional audit. Journal of General and Family Medicine 20:3, pages 101-106.
Crossref
Kuei-Chen Lee, Yung-Tsan Wu, Liang-Cheng Chen, Chih-Hao Shen, Chi-Hsiang Chung, Wu-Chien Chien & Yi-Shing Shieh. (2019) Chronic obstructive pulmonary disease combined with vertebral compression fracture increases the risk of temporomandibular disorder. Medicine 98:37, pages e17162.
Crossref
Pedro Assed Gonçalves, Rafael dos Santos Neves, Leonardo Vieira Neto, Miguel Madeira, Fernando Silva Guimarães, Laura Maria Carvalho Mendonça, Agnaldo Jose Lopes & Maria Lucia Fleiuss Farias. (2017) Inhaled glucocorticoids are associated with vertebral fractures in COPD patients. Journal of Bone and Mineral Metabolism 36:4, pages 454-461.
Crossref
Beth Hahn, Michael Hull, Cori Blauer-Peterson, Ami R. Buikema, Riju Ray & Richard H. Stanford. (2018) Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA. Respiratory Medicine 139, pages 65-71.
Crossref
Cristine CazeiroCristina Silva, Susana Mayer, Vanessa Mariany, Claire Elizabeth Wainwright & Linjie Zhang. (2017) Inhaled Corticosteroids and Respiratory Infections in Children With Asthma: A Meta-analysis. Pediatrics 139:3.
Crossref
Claus Vogelmeier, Pier Luigi Paggiaro, Jordi Dorca, Pawel Sliwinski, Marcel Mallet, Anne-Marie Kirsten, Jutta Beier, Beatriz Seoane, Rosa Maria Segarra & Anne Leselbaum. (2016) Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD study . European Respiratory Journal 48:4, pages 1030-1039.
Crossref
Wei Du, Jinyu Su, Dan Ye, Yuegang Wang, Qiaobing Huang & Xiaowei Gong. (2016) Pinellia ternata Attenuates Mucus Secretion and Airway Inflammation after Inhaled Corticosteroid Withdrawal in COPD Rats . The American Journal of Chinese Medicine 44:05, pages 1027-1041.
Crossref
Linda Bryant. (2016) Nuggets of Knowledge: COPD – targeting the use of inhaled corticosteroids. Journal of Primary Health Care 8:1, pages 83.
Crossref